Keeping in mind the current uncertainty over the function of brain BGT1, further studies will be required to clarify the effect of changing GABA transporter expression patterns and the relevance of any potential compensatory mechanisms in the maintenance of synaptic and extrasynaptic GABA levels and cellular osmoregulation in AD. The gene discussed is SLC6A12; the disease is Alzheimer disease.